IgA nephropathy

Current Opinion in Pediatrics

Volumn 11, Issue 2, 1999, Pages 152-157

  Hunley, Tracy E ^a   Kon, Valentina ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; IMMUNOGLOBULIN A;

CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE COURSE; GENETIC VARIABILITY; GLOMERULUS; HEMATURIA; HISTOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; OUTCOMES RESEARCH; PARENCHYMA; PEDIATRICS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; TISSUE INJURY;

DISEASE PROGRESSION; GLOMERULONEPHRITIS, IGA; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 0032938392     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199904000-00009     Document Type: Review

References (56)

1. 1 Berger J, Hinglais N: Les depots intercapillaires d'IgA-IgG. J Urol Nephrol 1968, 74:694-695.
2. 2 D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987, 245:709-727.
3. 3 Levy M, Berger J: Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988, 12:340-347.
4. 4 Galla JH: IgA nephropathy. Kidney Int 1995, 47:377-387.
5. 5 Ueda Y, Sakai O, Yamagata M, Kitajima T, Kawamura K: IgA glomerulonephritis in Japan. Contrib Nephrol 1977, 4:36-47.
6. 6 Wyatt RJ, Julian BA, Baehler RW, Stafford CC, McMorrow RG, Ferguson T, et al.: Epidemiology of IgA nephropathy in central and eastern Kentuky for the period 1975 through 1994. J Am Soc Nephrol 1998, 9:853-858. Increased recognition of IgA nephropathy in the United States has been documented over the last two decades.
7. 7 Galla JH, Kohaut EC, Alexander RC, Mestecky J: Racial differences in the prevalence of IgA-associated nephropathies. Lancet 1985, ii:522.
8. 8 Jennette JC, Wall SD, Wilkman AS: Low incidence of IgA nephropathy in blacks. Kidney Int 1985, 28:944-950.
9. 9 Sehic AM, Gaber LW, Roy S III, Miller PM, Kritchevsky SB, Wyatt RJ: Increased recognition of IgA nephropathy in African American children. Pediatr Nephrol 1997, 11:435-437. Heretofore, blacks have not been thought to suffer from IgA nephropathy in significant numbers. This study finds that the incidence of IgA nephropathy in black children does not differ remarkably from that in white children.
10. 10 Meleg-Smith S, Tung KSK: Incidence of IgA-related nephritides in American Indians in New Mexico. Hum Pathol 1985, 16:181-184.
11. 11 Julian BA, Quiggins PA, Thompson JS, Woodford SY, Gleason K, Wyatt RJ: Familial IgA nephropathy: evidence for an inherited mechanism of disease. N Engl J Med 1985, 312:202-208.
12. 12 Linné T, Berg U, Bohman S-O, Sigström L: Course and long-term outcome of idiopathic IgA nephropathy in children. Pediatr Nephrol 1991, 5:383-386.
13. 13 Southwest Pediatric Nephrology Study Group: A multicenter study of IgA nephropathy in children. Kidney Int 1982, 22:643-652.
14. 14 Hogg RJ: IgA nephropathy: clinical features and natural history: a pediatric perspective. Am J Kidney Dis 1988, 12:358-361.
15. 15 Yoshikawa N, White RHR: IgA nephropathy. In Pediatric Nephrology, edn 3. Edited by Holliday MA, Barratt TM, Avner ED. Baltimore: Williams & Wilkins; 1994:719-728.
16. 16 Ibels LS, Gyory AZ, Caterson RJ, Pollock CA, Mahony JF, Waugh DA, et al.: Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairment. Kidney Int 1997, 52(suppl): S67-S70.
17. 17 Southwest Pediatric Nephrology Study Group: A clinico-pathologic study of crescentic glomerulonephritis in 50 children. Kidney Int 1985, 27:450-458.
18. 18 D'Amico G: Pathogenesis of immunoglobulin A nephropathy. Curr Opin Nephrol Hypertens, 1998:247-250.
19. 19 D'Amico G, Harper SJ, Feehally J: The pathogenic role of immunoglobulin A polymers in immunoglobulin A nephropathy. Nephron 1993, 65:337-345.
20. 20 Conley ME, Cooper MD, Michael AF: Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis and systemic lupus erythematosus. J Clin Invest 1980, 66:1432-1436.
21. 21 Tomino Y, Endoh M, Nomoto Y, Sakai H: Immunoglobulin A1 in IgA nephropathy. N Engl J Med 1981, 305:1159-1160.
22. 22 Tomana M, Matousivoc K, Julian BA, Radl J, Konecny K, Mestecky J: Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1977, 52:509-516.
23. 23 Feehally J: IgA nephropathy: a disorder of IgA production? Q J Med 1997, 90:387-390.
24. 24 Hiki Y, Kokubo T, Iwase H, Masaki Y, Tanaka Y, Toma K, et al.: A certain role of under-O-glycosylation of IgA1 hinge for its glomerular deposition in IgA nephropathy [abstract]. J Am Soc Nephrol 1998, 9:72A.
25. 25 Allen AC, Topham PS, Harper SJ, Feehally J: Leucocyte β 1, 3 galactosyl-transferase activity in IgA nephropathy. Nephrol Dial Transplant 1997, 12:701-706. This intriguing study identifies an enzyme defect that may be a fundamental pathogenic abnormality in IgA nephropathy.
26. 26 Kukubo T, Hiki Y, Iwase H, Tanaka A, Nishikido J, Hotta K, Kobayashi Y: Effect of deglycosylation of IgA hinge region on IgA self-aggregation and adhesion to ECM proteins [abstract]. J Am Soc Nephrol 1997, 8:459A.
27. 27 Tomana M, Kulhavy R, Mestecky J: Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 1988, 94:762-770.
28. 28 Freese P, Norden G, Nyberg G: Morphologic high-risk factors in IgA nephropathy. Nephron 1998, 79:420-425.
29. 29 D'Amico G: Clinical features and natural history in adults with IgA nephropathy. Am J Kidney Dis 1988, 12:353-357.
30. 30 Lai K-N, Chui S-H, Lai FM, Lam CWK: Predominant synthesis of IgA with lambda light chain in IgA nephropathy. Kidney Int 1988, 33:584-589.
31. 31 Baldree LA, Wyatt RJ, Julian BA, Falk RJ, Jeannette JC: Immunoglobulin A-fibronectin aggregate levels in children and adults with immunoglobulin A nephropathy. Am J Kidney Dis 1993, 22:1-4.
32. 32 Czerkinsky C, Crago SS, Koopman WJ, Jackson S, Schrohenloher RE, Galla J, Mestecky J: The occurrence of circulating IgA-IgG immune complexes in IgA associated renal diseases. In Mucosal Immunity, IgA and Polymorphonuclear Neutrophils. Edited by Revillard JP, Viosin C, Wierzbicki N. Suresnes, France: Foundation Francoallemande; 1985:295-297.
33. 33 D'Amico G, Imbasciati E, Barbiano Di Belgiosioso G, Bertoli S, Fogazzi G, Ferrario F, et al.: Idiopathic IgA mesangial nephropathy: clinical and histological study of 374 patients. Medicine (Baltimore) 1985, 64:49-60.
34. 34 Droz D, Kramar A, Nawar T, Noel LH: Primary IgA nephropathy: prognostic factors. Contrib Nephrol 1984, 40:202-207.
35. 35 Yoshikawa N, Ito H, Nakamura H: IgA nephropathy in children from Japan. Child Nephrol Urol 1989, 9:191-199.
36. 36 Costa RS, Droz D, Noel LH: Longstanding spontaneous clinical remission and glomerular involvement in primary IgA nephropathy (Berger's disease). Am J Nephrol 1987, 7:440-445.
37. 37 Yoshikawa N, Iijima K, Matsuyama S, Suzuki J, Kameda A, Okada S, Nakamura H: Repeat renal biopsy in children with IgA nephropathy. Clin Nephrol 1990, 33:160-167.
38. 38 Radford MG Jr, Donadio JV, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1996, 8:199-207.
39. 39 Yoshikawa N, Ito H, Yoshiara S, Nakahara C, Yoshiya K, Hasegawa O: Clinical course of IgA nephropathy in children. J Pediatr 1987, 110:555-560.
40. 40 Yoshikawa N, Ito H, Iijima K, Nakahara C, Maehara K, Hasegawa O: Macroscopic hematuria in childhood IgA nephropathy. Clin Nephrol 1987, 28:217-221.
41. 41 Vasishtha S, Gauthier B, Valderrama E, Trachtman H: Acute interstitial nephritis associated with IgA nephropathy in children. Pediatr Nephrol 1997, 11:12-15.
42. 42 Wyatt RJ, Julian BA, Woodford SY, Wang C, Roberts J, Thompson JS, et al.: C4A deficiency and poor prognosis in patients with IgA nephropathy. Clin Nephrol 1991, 36:1-5.
43. 43 Berthoux FC, Alamartine E, Pommier G, Le Petit J-C: HLA B35 antigen as a prognostic factor. N Engl J Med 1988, 319:1609-1610.
44. 44 Freedman BI, Spray BJ, Heise ER: HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am J Kidney Dis 1994, 23:352-357.
45. 45 Matsusaka T, Hymes J, Ichikawa I: Angiotensin in progressive renal diseases: theory and practice. J Am Soc Nephrol 1996, 7:2025-2043.
46. 46 Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin converting enzyme inhibitor on diabetic nephropathy: the Collaborative Study Group. N Engl J Med 1993, 329:1456-1462.
47. 47 Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, et al.: Effect of the angiotensin converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996, 334:939-945.
48. 48 Cattran DC, Greenwood C, Ritchie S: Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 1994, 23:247-254.
49. 49 Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
50. 50 Hunley TE, Julian BA, Phillips JA III, Summar ML, Yoshida H, Horn RG, et al.: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996, 49:571-577.
51. 51 Yoshida H, Mitarai T, Kawamura T, Kitajima T, Kanai T, Miyazaki Y, et al.: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995, 96:2162-2169.
52. 52 Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Stuart R, et al.: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995, 345:1540-1542.
53. 53 Tanaka R, Iijima K, Murakami R, Koide M, Nakamura H, Yoshikawa N: ACE gene polymorphism in childhood IgA nephropathy: association with clinico-pathologic findings. Am J Kidney Dis 1998, 31:774-779.
54. 54 Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe AJ, et al.: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995, 26:727-731.
55. 55 Pei Y, Scholey J, Thai K, Suzuki M, Cattran D: Association of angiotensinogen gene T235 variant with progression of immunoglobulin A nephropathy in caucasian patients. J Clin Invest 1997, 100:814-820.
56. 56 Hogg RJ: A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study. Am J Kidney Dis 1995, 26:792-796.